USANA Health Sciences Inc
$ 19.73
-0.55%
29 Dec - close price
- Market Cap 360,681,000 USD
- Current Price $ 19.73
- High / Low $ 19.81 / 19.44
- Stock P/E 21.92
- Book Value 28.90
- EPS 0.90
- Next Earning Report -
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.04 %
- ROE 0.03 %
- 52 Week High 38.32
- 52 Week Low 18.48
About
USANA Health Sciences, Inc. is a leading developer and manufacturer of science-based nutritional supplements and personal care products, committed to enhancing health and wellness globally. Headquartered in Salt Lake City, Utah, the company leverages a direct selling model to distribute its products in numerous international markets. Renowned for its innovation and adherence to high-quality standards, USANA has established a solid reputation within the health and wellness industry, positioning itself advantageously to capitalize on the growing global demand for premium wellness products and solutions.
Analyst Target Price
$39.00
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-10-28 | 2025-07-21 | 2025-04-28 | 2025-02-04 | 2024-10-22 | 2024-07-23 | 2024-04-30 | 2024-02-06 | 2023-10-24 | 2023-07-25 | 2023-04-25 | 2023-02-07 |
| Reported EPS | -0.15 | 0.74 | 0.73 | 0.64 | 0.56 | 0.54 | 0.86 | 0.87 | 0.59 | 0.89 | 0.95 | 0.66 |
| Estimated EPS | 0.65 | 0.54 | 0.7 | 0.49 | 0.49 | 0.65 | 0.69 | 0.52 | 0.64 | 0.7 | 0.77 | 0.35 |
| Surprise | -0.8 | 0.2 | 0.03 | 0.15 | 0.07 | -0.11 | 0.17 | 0.35 | -0.05 | 0.19 | 0.18 | 0.31 |
| Surprise Percentage | -123.0769% | 37.037% | 4.2857% | 30.6122% | 14.2857% | -16.9231% | 24.6377% | 67.3077% | -7.8125% | 27.1429% | 23.3766% | 88.5714% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: USNA
2025-12-23 12:09:03
The USANA Foundation's annual holiday food pack initiative delivered 205,720 meals to 65 schools across Utah, ensuring children had access to nutritious food during winter break. This effort involved 632 volunteers and complemented the year-round USANA Kids Eat program, which in 2025 provided 327,166 meals to 49 schools. The initiative highlights the ongoing fight against childhood food insecurity in Utah.
2025-12-16 15:20:00
USANA's Probiotic supplement has received the ConsumerLab.com Seal of Approval, recognizing its high standards for purity, potency, and scientific accuracy. This certification validates USANA's commitment to providing premium, trustworthy products that support gut health. The probiotic contains researched strains like Lactobacillus rhamnosus GG and Bifidobacterium BB-12, formulated for survivability and stability.
2025-12-16 12:09:19
USANA's Probiotic supplement has received the distinguished ConsumerLab.com Seal of Approval, indicating it meets high standards for purity, potency, and scientific accuracy. This certification validates USANA's commitment to quality in providing a product designed to support healthy digestion, nutrient absorption, and overall well-being. The probiotic contains well-researched strains like Lactobacillus rhamnosus GG and Bifidobacterium BB-12, supported by technology ensuring bacterial viability.
2025-12-16 12:09:19
USANA's Probiotic supplement has received the ConsumerLab.com Seal of Approval after comprehensive third-party testing confirmed its purity, potency, viability, and label accuracy. The product, containing Lactobacillus rhamnosus GG (LGG) and Bifidobacterium BB-12, is designed to support gut health and maintain stated bacterial levels through expiration. This certification reinforces USANA's commitment to quality amidst a backdrop of mixed stock reactions to recent positive announcements.
2025-12-11 19:09:47
USANA Health Sciences (NYSE:USNA) insider David Mulham Mulham sold 873 shares of the company's stock on December 10th at an average price of $21.00, totaling $18,333.00. This sale decreased his stake by 9.43% to 8,387 shares. The transaction, disclosed in an SEC filing, occurred as USNA traded down 1.9% to $20.47 on light volume, with analysts generally rating the stock as "Hold/Reduce."
2025-12-11 18:09:47
David Mulham, Chief Sales Officer of Usana Health Sciences Inc (USNA), sold 873 shares of the company on December 10, 2025, reducing his holdings to 8,387 shares. Over the past year, there have been 18 insider sells and no insider buys at USNA. The stock is currently trading at $21, significantly undervalued based on its GF Value of $48.24.
